Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SLC50A1 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
mRNA | C1orf43 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | MFSD2B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | NRROS | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
mRNA | MCEE | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | PIAS3 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
mRNA | GAGE12J | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | C7orf34 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | UBE2Q1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | PI4KB | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |